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Germ line transformation of mammals by pronuclear
microinjection
Abstract
The most popular approach for generating transgenic mammals is the direct injection of transgenes into
one pronucleus of a fertilized oocyte. In the past 15 years microinjection has been successfully applied
in laboratory as well as in farm animals. The frequency of transgenic founders, although highly different
between the species, is efficient enough to render this technique applicable to a wide range of mammals.
The expression levels and patterns of a transgene are initially influenced by the construction of the
transgene. However, the overall phenotype of a transgenic organism is influenced by several genetic and
environmental factors. Due to the features of this technique not all of the genetic factors can be
experimentally controlled by the scientist. In this article we will emphasize some peculiarities which
have to be taken into account for the successful performance of transgenesis by pronuclear
microinjection.
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Introduction: methods of transgenesis
In 1981 Gordon and Ruddle introduced the term ‘transgenic’
in relation to mice genetically modified by transmission of
foreign DNA into early embryos. Today it is applied to the
characterization of an animal whose genome has been altered
by the stable integration of an in vitro recombined genetic
sequence.
Three different methods are routinely used to generate
transgenic animals: (i) transfection of early embryos with
recombinant retroviruses carrying the gene of interest,
(ii) pronuclear microinjection of DNA into a zygote and
(iii) gene transfer into pluripotent embryonic stem (ES) cells,
originally isolated from the inner cell mass of a blastocyst.
Recently, a fourth method has been introduced. The
transmission of foreign DNA was successfully performed by
intracytoplasmatic coinjection of unfertilized mouse oocytes
with sperm heads whose membranes had been disrupted
(Perry et al. 1999). If reproducible, this procedure has a
potential as a method for transgenesis in the future.
The aim of transgenesis is the establishment of a transgenic
line. Because of the early differentiation between soma and
germ line in mammals, genetic experiments have to be carried
out as early as possible during ontogenesis. Therefore, pre-
implantation stage embryos are preferentially used (Rulicke,
1996).
Both infection with retroviral vectors and microinjection of
naked DNA are restricted to the addition of DNA sequences,
whereas gene targeting in cultured ES cells can alter an
endogenous gene by homologous recombination of a
chromosomal locus with the transfected DNA molecule.
Depending on the field of application each of these methods
has its advantages as well as limitations.
The importance of retroviral vectors for the generation of
transgenic animals has decreased markedly and was gradually
replaced by pronuclear microinjection since these vectors are
limited to about 8 kb of foreign DNA. Furthermore, particular
viral sequence motifs appear to suppress the expression of
transgenes and the retroviral vectors are associated with a
certain biohazard risk. Nevertheless, retroviral vectors have
been used in avian species where the generation of transgenic
animals through microinjection of naked DNA is particularly
difficult and not yet routinely applicable.
The ES cell technique, although of great interest in other
model organisms and in livestock species, has been
successfully used only in the mouse so far. Plenty of very
valuable mouse mutants have been generated by this approach.
They include either a loss-of- or a gain-of-function mutation.
Recent developments in nuclear transfer technology could
provide an alternative tool to circumvent the lack of ES cells
in other mammalian species.
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The most popular approach for generating transgenic
mammals is direct injection of transgenes into one pronucleus
of a fertilized oocyte. In the last 15 years microinjection has
been successfully applied in laboratory as well as in farm
animals. The frequency of transgenic founders, although highly
different between the species, is efficient enough to render this
technique applicable to a wide range of mammals.
In this article, we consider only pronuclear microinjection. We
will emphasize some peculiarities, which have to be taken into
account for the successful performance of transgenesis by this
technique.
Pronuclear microinjection of mouse oocytes
Fertilized oocytes for microinjection are recovered from the
oviduct of mated female mice after superovulation. The timing
of development through the first cell cycle is shown in Fig. 1.
Mouse pronuclei are easily visible during the S-phase, the time
frame when the first round of DNA replication takes place.
The early female pronucleus is located not far from the second
polar body where meiosis was completed after fertilization
(Fig. 2A). About 6 h later both pronuclei show increased size
and are centrally positioned (Fig. 2C). The size and visibility
of both pronuclei are mainly influenced by the oocyte, i.e. by
the genotype (strain) of the female. For microinjection the
male pronucleus is preferred because of its larger size and
better position (Fig. 2B).
The two pronuclei differ in their DNA structure. In oocytes,
the maternal genome is packaged into chromatin. The paternal
genome arrives packaged in protamines that are replaced with
histones provided by the egg after fertilization (Zirkin et al.
1989). However, there is apparently no difference in the
number of transgenic offspring after injection into male or
female pronuclei (Brinster et al. 1985).
For the microinjection the zygotes are immobilized with a
holding pipette (Fig. 2B). The oocytes which survive the
injection procedure (about 40—90%, depending on the
occupational skill) are transferred into the oviduct of a pseudo-
pregnant surrogate mother. In our hands, about 20% of the
transferred embryos develop to term and more than 20% of
these live-born offspring are transgenic founders resulting in
an overall yield of 1.6—3.2%.
Integration characteristics of the pronuclear injected
transgenes
During microinjection about 1—2 pl of DNA solution are
transferred into one pronucleus. The injection buffer typically
contains 2 ng DNA ìl¢. Depending on the size of the
transgene each zygote receives tens to several hundreds of
linearized DNA molecules. Before chromosomal integration
takes place, the injected DNA molecules recombine to large
tandemly arranged concatemers. Although the dominant
intermolecular recombination mechanism in mammalian cells
is non-homologous, the predominant head-to-tail array strongly
suggests a process of homologous recombination between
multiple copies (Brouillette & Chartrand, 1987; Bishop &
Smith, 1989).
The integration of pronuclear injected DNA was
demonstrated by in situ hybridization in diverse regions of
the mouse genome (Michalova et al. 1988; Festenstein et al.
1996; Dobie et al. 1996; Boyer et al. 1997). These
observations supported the assumption that integration sites of
transgenes are randomly distributed at unreproducible
chromosomal sites. Homologous recombinations of pronuclear
injected constructs with an endogenous locus is extremely
infrequent (Brinster et al. 1989).
Only 13.2% of all founders produced in our laboratory had
multiple unlinked insertions in more than one chromosomal
site, suggesting that the integration of transgenes is determined
by rare nuclear events. It seems reasonable to assume that
illegitimate end-joining after DNA strand breaks is the main
route of randomly distributed chromosomal integration of
pronuclear injected transgenes.
It is quite possible that the procedure of microinjection itself
could induce random chromosomal damage leading to
preferentially used integration sites. In addition to random
DNA strand breaks, the activity of DNA topoisomerase I may
play a role in the insertion process (Konopka, 1988). As a result
of so-called non-homologous or illegitimate recombination
there exists probably more than one mechanism of transgene
integration.
Microinjected DNA can also persist for several days as free
molecules. The distribution of foreign DNA between the
blastomeres of an embryo was not found to be due to early
T. Rulicke and U. Hubscher Exp. Physiol. 85.6590
Figure 1
The first cell cycle of mouse development after insemination. Insemination was 13.5 h post hCG-injection for
superovulation (Howlett & Bolton, 1985). I, insemination; F, in vitro fertilization; P, start formation of
pronuclei; R, DNA replication; 4, time period for microinjection; T, first cell devision; M II, meiosis II; G,
gap phase (either G1 or G2); S, DNA synthesis; M, mitosis.
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concatemerization (Cousens et al. 1994). Consequently, there
is ample opportunity for an integration event in single
blastomeres after the first round of DNA replication. Indeed,
in our laboratory almost 7.6% of all founders were genetic
mosaics without germ line transmission while 31.1% were
mosaics with germ line transmission (Rulicke & Mertens,
1999).
Non-homologous recombination of microinjected DNA can
cause severe genetic alterations in the flanking chromosomal
regions (Covarrubias et al. 1986; Wilkie & Palmiter, 1987;
Kohrman et al. 1995). Such rearrangements include deletions,
duplications and translocations. This is directly opposed to the
integration of retroviral vectors which merely induce a
duplication of four to six base pairs of the flanking sequence
(Coffin, 1996).
Inheritance and expression of pronuclear injected
transgenes
Stable integrated transgenes are usually transmitted to the
offspring in a Mendelian fashion. Variations of the expected
ratio can be caused by founders containing mosaic germ line or
multiple integration sites. Furthermore, X- or Y-chromosomal
integrations, detrimental insertional mutations or harmful
effects of the transgene product can affect the pattern of
inheritance.
The activity of transgenes can be measured at the levels of
mRNA (by Northern blot analysis) and protein (by immuno-
blots or functional analysis) or by physiological effects of the
transgene product itself. However, the overall phenotype of a
transgenic organism is influenced by several genetic and
environmental factors. Not all of these genetic factors shown
in Fig. 3 can be experimentally controlled by the scientist,
implicating that each founder line, even if harbouring an
identical transgene, is unique and has to be characterized
separately.
The expression levels and patterns are heritable properties of a
transgenic line. Both are initially influenced by the construction
of the transgene, such as the correct use of regulatory andÏor
coding sequences.
The construction of transgenes
In higher eukaryotes the regulation of gene expression is a
very complex macromolecular event. Although the expression
pattern of transgenes may be influenced by post-transcriptional
and post-translational processes, the regulation of transcription
per se is the most stringent way to control gene expression.
Gene activation and the rate of transcription depend on
different transcriptional control elements. Furthermore, some
of these cis-factors regulate the correct spatial and temporal
activity of a (trans-) gene, suggesting that each gene has a
Pronuclear microinjection in mammalsExp. Physiol. 85.6 591
Figure 2
Development of pronuclei and microinjection of DNA into the mouse zygote. A and C, development of
pronuclei (arrows), about 20 and 26 h post hCG-injection for superovulation; B, DNA-microinjection into
the male pronucleus; D, pronuclei disappear before the first cell division.
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unique arrangement and assortment of control elements.
Results of transgenic experiments suggested that the cis-
regulatory elements co-operate among each other and that the
complete set of a particular gene locus must be present for an
integration site-independent expression (Huber et al. 1994).
Transcription control elements of eukaryotic protein coding
genes are found in the core promoter and in other upstream/
downstream regulatory sequence motifs. Regulatory sequences
can function as binding sites for gene-specific transcription
factors, which can stimulate transcription directly through
interactions with components of the basal transcription
initiation complex (RNA polymerase II holoenzyme and the
basal transcription factors) or indirectly by preventing the
repressive effects of a closed chromatin structure.
The best characterized control element so far is the promoter
located immediately upstream of the transcription initiation
site. But a promoter alone is often unable to express a transgene.
This is frequently observed in transgenic mice carrying a
simple cDNA construct.
A second type of control element, the enhancer, is a DNA
sequence which stimulates transcription. An enhancer can
potentiate gene activity in a tissue-specific manner by binding
activating transcription factors (reviewed by Muller et al.
1988).
Mice of different founder lines usually show qualitatively and
quantitatively different patterns of gene expression. These so-
called position effects due to random sites of transgene
integration could be eliminated for transgenes harbouring a
cis-regulatory element known as the dominant control region
(DCR) or locus control region (LCR) (Grosveld et al. 1987;
Bonifer et al. 1990). LCRs are short stretches of DNA,
characterized by tissue-specific developmentally stable DNase-I
hypersensitive sites which are able to provide an open
chromatin structure to adjacent sequences even when the
transgene is integrated into heterochromatic centromere regions
of mouse chromosomes (Festenstein et al. 1996). LCRs have
been identified, for example, upstream of the globin gene
cluster and downstream of the CD2 gene (Orkin, 1990; Lake
et al. 1990). The chromatin opening activity and insulating
properties of LCRs may additionally be influenced by certain
other gene components, not always present in cDNA- and
hybrid constructs (Reitman et al. 1993). The â_globin LCR
for instance was incapable of conferring position-independent
expression onto the prokaryotic marker sequences of lacZ
(Guy et al. 1996). The effect of LCRs can also be influenced
by an increased copy number indicated in mice as age-
dependent silencing of transgene expression (Robertson et al.
1996).
Several other specific control elements have been described
that can improve the expression of transgenes. Matrix/scaffold
attachment regions (MARsÏSARs) are thought to be important
for the organization of chromatin into functional genetic
domains as a consequence of binding to the nuclear matrix
(Bode et al. 1992). Positive effects of MAR elements onto
accurate position-independent and copy number-dependent
expression have been reported for transgenic mice (McKnight
et al. 1992). Subsequent investigations, however, indicated
that the positive effects of MARs on transgene expression are
not universal but rather depend on the co_operation with other
regulatory elements (Thompson et al. 1994; Barash et al.
1996; Neznanov et al. 1996).
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Figure 3
Factors that influence the phenotype of a transgenic animal. The phenotype of an animal is the result of
different genetic and non-genetic factors. Besides the background genome, direct effects of the mutation, such
as the included regulatory non-coding as well as coding sequences, the integration site(s) and the number of
integrated copies of a transgene, are important. Non-genetic factors are, for instance, the housing conditions,
the husbandry during experiments and the microbiological environment.
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Chung et al. (1993) described a novel regulatory element near
the 5' boundary of the chicken â_globin gene. This element
insulated transgenes in Drosophila and mice without
accompanying activation or suppression effects (Chung et al.
1993; Wang et al. 1997). More recently, Siegfried et al. (1999)
have characterized an element from the CpG island sequence
(unmethylated CpG-dinucleotide rich segment of housekeeping
genes) of the hamster APRT locus that may improve transgene
expression due to the reduced de novo methylation of flanking
sequences up to 150 bp away.
Finally, two technical points have to be taken into account
during the construction and preparation of linear transgenes
for pronuclear injection. Firstly, prokaryotic sequences of the
cloning vector have to be removed from the transgene (Townes
et al. 1985; Shani, 1986). Secondly, the injected linear
constructs are prone to nuclease degradation. If a sequence
loss of more than 100 bp is observed non-essential flanking
regions have to be added to both sides of the construct (Kearns
et al. 1995).
cDNA or genomic sequences as source for transgenic
constructs. A comprehensive knowledge of the specific gene
is required in order to provide defined transgene expression in
a quantitative and qualitative manner. For many interesting
candidate proteins only the cDNA sequences but not the
specific regulatory elements are currently available. Therefore,
in transgenes using cDNA, the promoter of the gene to be
mimicked is routinely combined with a heterologous enhancer,
introns and polyadenylation signals. Such a transgene often
results in an unpredictable expression level. Furthermore,
tissue- or developmental stage-specific isoforms of (trans-)
gene products may be the result of alternative splicing, a
process that cannot occur when cDNA constructs were used
for microinjection.
In experiments for the reconstitution of the knockout mouse
for the prion protein (PrP) we have injected three different
constructs of the murine PrP coding locus as transgenes
(Fischer et al. 1996). Transgenic mice harbouring 40 kbp of
the complete genomic sequence including both introns and the
flanking regions showed the expected PrP expression. To
facilitate mutagenesis, a half genomic PrP minigene was
constructed from which the large downstream intron and the
downstream flanking region had been deleted (Fig. 4).
In all but one of six lines carrying this construct, PrP was
correctly expressed. However, different levels of expression
between the founder lines indicated a stronger sensitivity
against position effects of the half-genomic construct. In
contrast, all eight transgenic lines containing the cDNA
construct had no detectable levels of PrP. Although we cannot
exclude the loss of an unknown regulatory sequence with the
upstream intron, the missing expression of the cDNA is
probably due to the general lack of introns. A requirement of
introns for efficient transgene expression in vivo has been
described previously (Brinster et al. 1988; Whitelaw et al.
1991; Palmiter et al. 1991). Introns can improve expression of
transgenic constructs by different mechanisms. (i) Through
cis-acting control elements within intron sequences. (ii) The
correct splicing process might influence transgene expression
through an enhanced mRNA stability. (iii) The introduction of
a generic intron that consists only of an splice donor and a
splice acceptor site stimulates the expression of a transgene
compared with the construct without any intervening
sequence (Choi et al. 1991). (iv) The loss of introns in cDNA
constructs might lead to an unnatural sequence that effects
chromatin structure, i.e. the nucleosome arrangements that
may prevent transcription initiation or elongation (Liu et al.
1995).
Pronuclear microinjection in mammalsExp. Physiol. 85.6 593
Figure 4
Constructs encoding wild-type PrP for reintroduction into Prn-p
tm1
knockout mice. E1—3, exons; I1—2,
introns; + or −, PrP expression of transgenic mice monitored by Northern analysis (mRNA) or Western blots
(protein) of total mouse brain homogenates. The cDNA construct showed no detectable levels of prion protein
and no or only very weak expression of Prn-p mRNA (+).
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Most interestingly, in mice containing the half-genomic PrP-
minigene we found no PrP mRNA in Purkinje cells, PrP
mRNA is normally abundant in wild-type as well as in PrP
knockout animals that have been reconstituted with the genomic
sequence. This suggested that a control element which is
essential for Purkinje cell-specific PrP expression was lost
within the half-genomic minigene (deletion of the 12 kbp
intron and the 3' flanking region).
The take home message from this work is to employ genomic
constructs for generation of transgenic animals whenever
possible. This should be followed by the construction of (half-)
genomic minigenes in which large intronic regions are removed
to facilitate transgenesis.
Other strategies were also developed for construction of
minigenes in order to circumvent the problems related to
cDNA. Moreover, for an ectopic, conditional or inducible
expression of transgenes the coding region must at least be
coupled with heterologous regulatory sequences.
The leakage of essential regulatory elements and the necessity
of introns for RNA splicing to produce stable RNA can, for
example, be solved with the insertion of the cDNA into a
complete or incomplete heterologous genomic locus. In this
way the viral src-kinase and the human Foamy virus env-gene
were expressed in a tissue-specific manner after cloning the
cDNA into the first exon of the genomic Gfap-sequence
(Weissenberger et al. 1997; Lampe et al. 1997). The risk of
this strategy is that artificial exons are skipped (Muller et al.
1994; Davisson et al. 1996) or that cryptic splice sites in large
exon sequences are used (reviewed by Berget, 1995). Such
constraints can be bypassed with the use of an internal
ribosomal entry site (IRES). Such sequences are provided by
viruses from the picorna family. IRES sequences act as a
ribosome landing pad and mediate the translation of di- as
well as polycistronic constructs (Pelletier & Sonenberg, 1988).
This strategy allows the cDNA to be preferably positioned in
the 3' untranslated region of an intact gene and lowers the risk
of skipping (Kim et al. 1992; Mountford et al. 1994; Vaulont
et al. 1995). However, since the IRES sequences are of viral
origin they could become the target of host defence
mechanisms.
Cloning and microinjection of large DNA fragments. If
the intention is to express a transgene in its native pattern the
best approach is to transfer the gene as an entire genomic
locus. Since many eukaryotic genes span large regions of
DNA, it excludes the use of traditional cloning vectors and
standard microinjection procedures. Large transgenes can be
cloned as overlapping DNA fragments and coinjected in
equimolar amounts. The functional transgene can be efficiently
reconstructed by homologous recombination between the
DNA molecules after injection (Pieper et al. 1992; Keegan et
al. 1994). Up to 300 kbp DNA fragments can be cloned with
bacteriophage P1 artificial chromosomes (PACs) (Ioannou et
al. 1994) or bacterial artificial chromosomes (BACs) (Shizuya
et al. 1992). Very large genomic loci extending several
hundreds of kilobase pairs can be handled via yeast artificial
chromosomes (YACs) and transferred under special conditions
by pronuclear injection (Burke et al. 1987; Gnirke et al. 1993;
Schedl et al. 1993a,b). The small aperture of the micro-
injection needle (< 1 ìm) causes likely shearing for large DNA
molecules. Low concentrations of polyamines in combination
with high salt concentrations can protect DNA from shearing
(Montoliu et al. 1994; Mrkic et al. 1998).
The transmitted number of YAC molecules per injected
oocyte is very low compared with injection of traditional
transgenes. A DNA concentration of higher than 10 ng (ìl
injection buffer)¢ may lead to a reduction in survival of the
injected zygotes (Brinster et al. 1985). Nevertheless, the
resulting frequencies of transgenic offspring after YAC
injection varies between 5 and 21% and is only slightly lower
than after injection of hundreds of small constructs (Schedl et
al. 1993a,b; Peterson et al. 1995, 1996; Heard et al. 1996;
Mrkic et al. 1998).
Position effects on transgene expression
The expression of pronuclear injected transgenes is often
highly variable between different lines containing an identical
construct. This is mainly due to the random integration sites.
The position effects can be caused by integration into, for
example: the direct vicinity of transcription control elements
of a host gene, a region of imprinting, a non-transcribed
heterochromatin region and X- or Y-chromosomes.
Transcription interference and insertional mutations
after random integration. The effect on transcription by cis-
acting endogenous regulatory DNA sequences has been
demonstrated by spatial and temporal variable expression
patterns in different transgenic lines with randomly integrated
marker genes (Kothary et al. 1988; Allen et al. 1988).
Position effects are exerted most strongly on those transgenes
with tightly controlled promoters and that do not contain
further regulatory sequences such as an enhancer (Muller et
al. 1988), a locus control region (Grosveld et al. 1987;
Palmiter et al. 1993) or a CpG island element (Siegfried et al.
1999). Al-Shawi et al. (1990) demonstrated the influence of
the random integration site by the isolation of a poorly
expressed transgene locus from a mouse line. After
reintegration of the isolated array, the secondary transgenic
mice showed the expected expression level comparable to
other transgenic lines harbouring the identical construct.
Although difficult to prove, it is also conceivable that the
activity of endogenous genes could be influenced by proximate
transgenic loci. Therefore, in a knock in approach the selection
marker of the targeting construct has to be removed after
homologous recombination.
Randomly integrated transgenes can induce insertional
mutations in endogenous genes, amplified by severe alterations
of flanking chromosomal regions. Although several thousand
transgenic lines have been published, the number of reported
insertional mutants is very low so far (reviewed by Rijkers
et al. 1994). Taking into account that only viable and fertile
mutants causing strong phenotypes were identified in
characterized lines, the real frequency of insertional mutations
should clearly be higher.
T. Rulicke and U. Hubscher Exp. Physiol. 85.6594
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Genomic imprinting and de novo methylation of
integrated transgenes. In a minority of transgenic lines, an
epigenetic mechanism known as genomic imprinting can be
observed in hemizygous animals (Reik et al. 1987; Swain et
al. 1987; Sapienza et al. 1989; De Loia & Solter, 1990; Sasaki
et al. 1991; Fafalios et al. 1996). A reversible gamete-specific
modification can lead to functional differences between
maternal or paternal inherited transgenes in hemizygous
offspring. Although many chromosomal regions of the mouse
genome are involved in genomic imprinting, imprinted
transgenes could so far never be exclusively attributed to a
positional effect.
An outstanding characteristic of transgene imprinting is the
almost complete restriction of transgene inactivation to the
female germ line and the influence of modifiers of the genetic
background (Sapienza et al. 1989; Engler et al. 1991;
Chaillet et al. 1991). In contrast to endogenous loci, where
imprinting takes part in the regulation of gene expression, the
inactivation of transgenes could be a host defence mechanism
against foreign DNA.
The differential imprinting of alleles of specific genes in the
human or mouse genome has been correlated with DNA
methylation (Li et al. 1993). Interestingly, the inactivation of
transgenes by de novo methylation has frequently been
observed in stable transfected cells and in transgenic mice.
Constructs containing viral sequences are especially susceptible
to this process (Palmiter et al. 1982; Wienhues & Doerfler,
1985; Koetsier & Doerfler, 1996; Betzl et al. 1996). This
observation supports the hypothesis that de novo DNA
methylation of transgenes can also be interpreted as a defence
mechanism against the activity of foreign genes in an
established genome.
The influence of heterochromatin and position effect
variegation on transgene expression. In mouse
chromosomes, A—T rich satellite DNA is localized in hetero-
chromatin near the centromere. Pericentric heterochromatin
can be visualized as a C-band and is characterized as a late
replicated and transcriptional inactive region. The capability
of heterochromatin to inactivate translocated euchromatic
sequences has been termed position effect variegation (PEV).
Primarily observed and investigated in Drosophila (reviewed
by Weiler & Wakimoto, 1995), PEV is also present as position
effect in transgenic mice. Transgene expression is usually
assumed to be uniform in specific cells of a tissue. But cell-by-
cell analysis of transgene-encoded molecules has shown that
even in mice of an established line a mosaic pattern of
transgene expression exists (Elliott et al. 1995; Festenstein et
al. 1996; Dobie et al. 1996; Boyer et al. 1997). Fluorescence
in situ hybridization analysis of transgene integration sites
indicates that this phenomenon is observed when the transgene
is located in the vicinity of pericentric heterochomatin. This
position-dependent effect results in the stochastic inactivation
of transgene expression in a subpopulation of cells of a
particular tissue. Furthermore, the percentage of expressing
cells declines with the increase in copy number within the
integrated array (Dorer & Henikoff, 1994).
Consequences of X- and Y-chromosomal integration. Sex
chromosomal integration of a transgene leads to special
features regarding its inheritance and expression. The analysis
of Y-chromosomal integrated transgenes is restricted to the
male gender. This most specialized mouse chromosome
consists predominantly of highly repeated DNA sequences
with no obvious function (Bishop, 1993). Additionally, because
of its extremely late replication during mitosis, characteristic
of heterochromatic segments, an optimal expression of
transgenes on the mouse Y-chromosome may not be expected
(Pravtcheva et al. 1994).
X-chromosomal integrated transgenes can be subjected to
modifications similar to those reported for endogenous X-linked
genes. The inactivation of one X-chromosome in female
mammals occurs with different schedules in different tissue
lineages of the conceptus. In female extraembryonic tissues,
the paternally derived X-chromosome (including the transgene)
was preferentially inactivated by 3.5—4.5 days postconception.
In somatic cell lineages the X-inactivation in most tissues was
completed by 9.5—10.5 days postconception. Hemizygous
female embryos displayed a mosaic pattern of transgene
expression in about 50% of the somatic cells, most probably
due to random inactivation of one X-chromosome per cell
(Tagaki & Sasaki, 1975; Tan et al. 1993). However, it has also
been reported that a transgene inserted into the X_chromosome
might completely escape X-chromosome inactivation (Goldman
et al. 1987). This could be due to integration in the X—Y
pairing region, which normally escapes X-inactivation.
Multicopy array and its influence on transgene
expression
The copy number of transgene concatemers varies usually
between one and about 100 (Fischer et al. 1996; Magyar et al.
1996; Weissenberger et al. 1997; Raeber et al. 1999).
However, an extreme tandem array of 1000 copies spanning an
insertion of 11000 kbp has been described (Lo et al. 1992;
Simon & Knowles, 1993). There is usually no correlation
found between the copy number and the expression level of
transgenes. However, for transgenes harbouring LCRs, a copy
number-dependent expression level was observed (Grosveld et
al. 1987; Bonifer et al. 1990). These results indicated that each
transgene copy can function as an independent regulatory unit.
Silencing of transgenes in animals with high copy number is a
frequent feature of pronuclear microinjection. Large tandem
arrays of repeated sequences may repress efficient transcription
of transgenes since inappropriate chromatin structures were
induced (Simon & Knowles, 1993; Dorer & Henikoff, 1994).
A twenty- to fiftyfold reduction post integration of a high copy
number array (from more than 100 to five, respectively one
copy) in two independent mouse lines resulted in a marked
increase in the expression level of the respective transgene.
Simultaneously, chromatin compaction and DNA methylation
at both recombined transgene loci were decreased (Garrick et
al. 1998).
Changes in chromatin structure after copy number reduction
suggest that the reduced transcription rate per integrated
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transgene is not primarily due to the limitations of essential
transcription factors. This also became clear by an increased
gene expression level observed in several homozygous and
hemizygous transgenic mice (Fischer et al. 1996; Senn et al.
2000).
Another form of (trans-) gene silencing that was unexpectedly
discovered in plants, fungi and, more recently, in Drosophila,
results from the interactions between homologous genes
(Cogoni et al. 1996; Metzlaff et al. 1997; Pal-Bhadra et al.
1997). By this interaction, which is called co-suppression, a
transgene can inactivate its endogenous counterpart or an
identical transgene that is integrated at another genomic
location. Co-suppression-associated gene silencing is most
probably induced by several mechanisms. Transcriptional
repression in conjunction with DNA methylation and repressive
chromatin structure, as well as post-transcriptional silencing
by elimination of RNA products have been described in several
cases (Matzke & Matzke, 1995; Baulcombe & English,
1996). Although most transgenes apparently do not produce
these effects, the progressive silencing with increasing dosage
of the transgene, as, for example, found in Drosophila, reflects
a biological process referred as a defence mechanism against
too many copies of a certain gene (Pal-Bhadra et al. 1997).
Effects of the genetic background
Transgenes integrated into an established genome have to
develop their function in concert with the many other genes of
the cell. Pleiotropic genes and polygenic traits can describe the
network of interaction between genotype and phenotype.
Phenotypic variations of transgenic lines after changing the
genetic background are known. These background effects were,
however, only rarely classified and systematically investigated.
The influence of background genes, also called modifiers, can
heavily influence the characteristics of a transgenic line
(Pircher et al. 1989; Baribault et al. 1994; Hsiao et al. 1995;
Rozmahel et al. 1996; Nagasawa et al. 1996; Bonyadi et al.
1997). These modifier genes can only be revealed by breeding
mutations (a certain transgenic locus) onto different genetic
backgrounds. To achieve this, the backcross of the transgene
into defined inbred strains is very helpful. This backcross
approach is primarily used to establish congenic lines. Marker-
assisted breeding (speed congenic) can reduce the time needed
for congenic-strain production (Markel et al. 1997).
In an undefined genetic background, the polymorphism of
modifier genes may be a source of variability that could
exacerbate the interpretation of experimental results (Gerlai,
1996; Wolfer et al. 1997). On the other hand, the recognition
of a modifier gene can be an interesting reference for a better
understanding of an observed phenotype or can improve a
particular mouse model.
Strategies for site-specific and single-copy
transgene integration
The possibility of a directed transgene integration into a
neutral chromosomal site would make the pronuclear injection
results more reproducible and comparable. Position effects on
transgene expression caused by random integration sites thus
could be eliminated and could be combined with the ability to
avoid undesired insertional mutations.
To achieve a directed transgene integration, the two site-
specific recombination systems of Cre—loxP and of FLP—FRT
were thought to be helpful. The simplicity of these experimental
systems has led to their widespread use as a tool for in vivo
DNA recombination. For example, Cre-recombinase was
successfully used to delete loxP-flanked fragments of
chromosomal integrated transgenes (Lakso et al. 1992).
Although recombination is a reversible process, the integration
(intermolecular recombination) is about two orders of
magnitude less efficient than the deletion (intramolecular
recombination) (Abremski et al. 1983). After site-specific
recombination, the integrated DNA fragment is flanked by
two loxP sites and therefore promptly excised as long as the
Cre-recombinase is present.
Several strategies were tried to generate a stable insertion
product. Most promising was the use of mutated loxP sites
combined with a transient provision of Cre-recombinase to
curtail the post-integration recombinase activity (Senecoff,
1988; Fukushige & Sauer, 1992; Baubonis & Sauer, 1993;
Albert et al. 1995). Because of very low efficiency this
strategy has proved so far to be inapplicable even when it is
combined with pronuclear injection (T. Rulicke, unpublished
results). Araki et al. (1997) succeeded in producing a Cre-
mediated single copy integration of transgenes into a mutated
chromosomal loxP site in murine ES cells. However, the
recombination frequency obtained was only comparable to
that of gene targeting via homologous recombination. A
similar approach by using mutated FRT sites in E. coli
reduced the recombination efficiency by a factor of 100
compared with the wild-type (Huang et al. 1991). Thus, the
enhanced stability of integration by the use of mutated loxP or
FRT sites is probably outweighed by a very inefficient forward
recombination.
Targeting a single copy of a transgene to a specific location in
the mouse genome can be performed with the help of
homologous recombination in ES cells. The transgenic
sequence is transferred as part of a targeting construct to the
target endogenous sequence. Particularly useful for this strategy
is the mutated Hprt locus: homologous recombination events
are directly selectable and the ubiquitously expressed locus
provides an optimal chromosomal environment for transgene
expression (Bronson et al. 1996). The targeting frequency
seems to be insensitive to the length of non-homologous DNA
in the vector, rendering this strategy absolutely available for
the site-directed integration of classical transgenic constructs
(Mansour et al. 1990).
Assessing transgenic animals
There is continuous and remarkable development in transgenic
technology, particularly in the quality of transgenes and
experimental approaches. Nevertheless, the consequences of
experimentally induced mutations cannot be completely
predicted. This is especially true for the majority of transgenic
animals that are generated by pronuclear injection. Even
T. Rulicke and U. Hubscher Exp. Physiol. 85.6596
 at Universitaetsspital, Bibliothek, CH-8091 ZUERICH on May 15, 2006 ep.physoc.orgDownloaded from 
though our experience shows that the welfare of the majority
of transgenic animals is not noticeably affected, randomly
integrated foreign DNA may increase the risk of disturbing
the normal physiology of an animal. The resulting phenotypic
changes may be crucial to the animals’ welfare already during
breeding and maintenance of a transgenic line. Apparent and
relevant phenotypic changes can only be determined after a
careful and comprehensive assessment (Mertens & Rulicke,
1999, 2000). This monitoring for phenotypic changes should
be done as early as possible, namely during the establishment
of a new transgenic line. Since each transgenic line produced
by pronuclear injection is unique, it has to be carefully
assessed separately by specialists.
Outlook
Pronuclear DNA injection has enabled the scientific
community world wide to selectively add defined genes of
choice into the germ line of laboratory as well as farm animals.
Many experiments with transgenic animals confirmed that
transgenesis can provide new insight into many aspects of
mammalian life, development and diseases.
Moreover, improved strategies allow the modification and
tightly controlled regulation of transgenes after chromosomal
integration. Most impressively, the conditional or inducible
activities of transgenes can be controlled in a specific
spatiotemporally regulated manner and provide great advance
in transgenic animal technology.
The use of conditional and inducible transgenic systems can
permit the study of a phenotype containing or lacking the
transgene product at any given developmental stage of the
same individual. This could enable experimental approaches
that can either focus on specific time points or in specific
tissues during ontogeny, on effects of the duration of transgene
expression and on the reversibility of induced phenotypes.
These strategies can take advantage, for example, of
prokaryotic recombination and transcriptional activation
systems such as Cre—loxP and tetRÏtetO (Hoess & Abremski,
1985; Gossen & Bujard, 1992). Recently, the Cre-system has
been developed as a standard genetic tool. The expression of
Cre-recombinase, for example, can be restricted to a given
cell type by the use of a tissue-specific promoter to dictate
specific transgene expression or suppression (For details see
the Cre-transgenic database: www.mshri.on.nagyÏCre-
pub.html). Other strategies to utilize steroid receptors and
their associated proteins are being tested in mice. To
accomplish tissue- and, additionally, time-specific transgene
regulation, the Cre enzyme can be expressed as a fusion
protein with a mutant estrogen receptor ligand-binding domain
which is exclusively responsive to the synthetic oestrogen
antagonist tamoxifen (Schwenk et al. 1998).
The tetracycline-regulated system is not yet fully developed to
guarantee success in each case. Some of the difficulties may
relate to variations between different cell types in their
interaction with tetracycline, as found in in vitro studies
(Ackland-Berglund & Leib, 1995). Moreover, mammalian
cells could be an inappropriate environment for processing the
bacterial tetR gene. It remains to be seen whether this and
other systems that are currently under investigation will be
more robust for application in transgenic animals.
Controlled simultaneous andÏor independent expression of
one or several transgenes simultaneously and independently in
the same organism is a powerful tool to study the gene
function and its physiological consequences. Novel methods
and systems for the creation of transgenic animal models
shows considerable promise and will broaden their scope of
application. As discussed in this review, it is also necessary to
bear in mind that highly sophisticated transgenic strategies
that are based on pronuclear injection can be subjected to
many possible influences.
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